- Home
- ZYME vs DEC Comparison
ZYME vs DEC Comparison
Compare ZYME & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- DEC
- Stock Information
- Founded
- ZYME 2003
- DEC 2001
- Country
- ZYME United States
- DEC United States
- Employees
- ZYME N/A
- DEC N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- DEC
- Sector
- ZYME Health Care
- DEC
- Exchange
- ZYME Nasdaq
- DEC Nasdaq
- Market Cap
- ZYME 1.2B
- DEC 1.2B
- IPO Year
- ZYME 2017
- DEC N/A
- Fundamental
- Price
- ZYME $18.08
- DEC $12.58
- Analyst Decision
- ZYME Strong Buy
- DEC Strong Buy
- Analyst Count
- ZYME 8
- DEC 4
- Target Price
- ZYME $24.00
- DEC $22.25
- AVG Volume (30 Days)
- ZYME 668.9K
- DEC 480.0K
- Earning Date
- ZYME 11-06-2025
- DEC 01-01-0001
- Dividend Yield
- ZYME N/A
- DEC 6.43%
- EPS Growth
- ZYME N/A
- DEC N/A
- EPS
- ZYME N/A
- DEC N/A
- Revenue
- ZYME $122,867,000.00
- DEC $1,148,432,000.00
- Revenue This Year
- ZYME $107.76
- DEC $128.26
- Revenue Next Year
- ZYME $2.35
- DEC N/A
- P/E Ratio
- ZYME N/A
- DEC N/A
- Revenue Growth
- ZYME 95.94
- DEC 64.19
- 52 Week Low
- ZYME $9.03
- DEC $10.08
- 52 Week High
- ZYME $19.50
- DEC $17.70
- Technical
- Relative Strength Index (RSI)
- ZYME 65.50
- DEC 31.62
- Support Level
- ZYME $18.21
- DEC $12.33
- Resistance Level
- ZYME $19.10
- DEC $12.85
- Average True Range (ATR)
- ZYME 0.69
- DEC 0.41
- MACD
- ZYME 0.02
- DEC -0.04
- Stochastic Oscillator
- ZYME 56.97
- DEC 14.45
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About DEC Diversified Energy Company plc
Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.